Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Head and Neck Neoplasms 3Colonic Neoplasms 3Chronic Pain 3Cancer Pain 3Supratentorial Neoplasms 2Pain, Postoperative 2Pain 2Neoplastic Cells, Circulating 2Neoplasms 2Colorectal Neoplasms 2Agnosia 2Substance Withdrawal Syndrome 1Stomach Neoplasms 1Rectal Neoplasms 1Neoplasm, Residual 1Nasopharyngeal Carcinoma 1Nalbuphine Allergy 1Ileus 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Constipation 1Breakthrough Pain 1Brain Neoplasms 1Age Problem 1Abdominal Cancer 1

Interventions

Pirinitramide 2Morphine 2Zoledronic Acid 1Standard of Care 1Sevoflurane 1Propofol 1Injections, Epidural 1Ethiodized Oil 1Epirubicin 1Diphosphonates 1Desflurane 1Chemoembolization, Therapeutic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Neoplastic Cells, Circulating × Morphine × Clear all
NCT03700411 2023-12-07

POACC-1

The Institute of Molecular and Translational Medicine, Czech Republic

Phase 4 Completed
125 enrolled
Gastrointestinal

Neoplastic Cells, Circulating, Colorectal Neoplasms

NCT03700541 2023-12-07

POACC-2

The Institute of Molecular and Translational Medicine, Czech Republic

Phase 4 Completed
71 enrolled
Gastrointestinal

Neoplastic Cells, Circulating, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡